Global Injectable Drug Delivery Market Size study, by Type (Self-Injectors, Needle-free Injectors, Auto-Injectors), by Usage (Disposable, Reusable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce) and Regional Forecasts 2022-2

Global Injectable Drug Delivery Market Size study, by Type (Self-Injectors, Needle-free Injectors, Auto-Injectors), by Usage (Disposable, Reusable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce) and Regional Forecasts 2022-2028

Global Injectable Drug Delivery Market is valued at approximately USD 624.5 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.50 % over the forecast period 2022-2028. Injectable Drug Delivery is drug delivery system that can be used instead of oral route of administration and is more effective due to its speed of action. Injectable medications are injected directly into the bloodstream using a syringe. As injectable drug delivery provides a vast surface area for absorption, it produces rapid systemic levels of absorption. Rise in demand for self-injectable devices, expanding biologics market and rising prevalence of chronic diseases have driven the adoption of Injectable Drug Delivery across the projected period. For Instance:Chronic diseases afflicted a major share of the Chinese population in 2020. More over 500 million people were overweight or obese, and more than 400 million people suffered from excessive blood pressure. Chronic diseases accounted for 88.5 percent of all fatalities in China in 2019. Also, rising technological advancements, rise in demand for Biosimilar and generic injectable and expanding manufacturing facilities are most likely to boost the overall growth of the Injectable Drug Delivery market. However, presence of alternative routes of administration, risk of infections with needlestick injuries and product recalls can obstruct the market's expansion over the projection period of 2021-2027.

The key regions considered for the global Injectable Drug Delivery market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising prevalence of chronic diseases and growing biologics market are driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. The market is expected to grow during the projected period, due to rising disposable income and growing partnerships among key players.

Major market players included in this report are:

Amgen Inc.
Antares Pharma Inc.
Becton Dickinson & Company
Consort Medical Plc
Crossjet Ltd
Medtronic Plc
Mylan N. V.
SHL Group
West Pharmaceutical Services
Ypsomed India Pvt. Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Self-Injectors
Needle-Free-Injectors
Auto-Injectors

By Usage:
Disposable Injectors
Reusable Injectors

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-commerce

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Injectable Drug Delivery Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Amgen Inc.
Antares Pharma Inc.
Becton Dickinson & Company
Consort Medical Plc
Crossjet Ltd
Medtronic Plc
Mylan N. V.
SHL Group
West Pharmaceutical Services
Ypsomed India Pvt. Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license will allow these actions.